A mutant TP53 gene status is associated with a poor prognosis and anthracycline-resistance in breast cancer patients

Autor: Rahko, E a, Blanco, G a, Soini, Y b, Bloigu, R c, Jukkola, A a, ∗
Zdroj: In European Journal of Cancer 2003 39(4):447-453
Databáze: ScienceDirect